JPH07116217B2 - Method for producing steroid compound - Google Patents

Method for producing steroid compound

Info

Publication number
JPH07116217B2
JPH07116217B2 JP22484386A JP22484386A JPH07116217B2 JP H07116217 B2 JPH07116217 B2 JP H07116217B2 JP 22484386 A JP22484386 A JP 22484386A JP 22484386 A JP22484386 A JP 22484386A JP H07116217 B2 JPH07116217 B2 JP H07116217B2
Authority
JP
Japan
Prior art keywords
compound
formula
steroid compound
mmol
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP22484386A
Other languages
Japanese (ja)
Other versions
JPS6383096A (en
Inventor
誠一 林
正 北条
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Priority to JP22484386A priority Critical patent/JPH07116217B2/en
Priority to US07/096,433 priority patent/US4891168A/en
Priority to IL83916A priority patent/IL83916A/en
Priority to EP87113893A priority patent/EP0261656A1/en
Priority to CN198787106588A priority patent/CN87106588A/en
Priority to KR870010614A priority patent/KR880003970A/en
Publication of JPS6383096A publication Critical patent/JPS6383096A/en
Publication of JPH07116217B2 publication Critical patent/JPH07116217B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は植物生長調節剤であるブラシノライド類縁体の
中間体として有用なステロイド化合物の製法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for producing a steroid compound useful as an intermediate for a brassinolide analog which is a plant growth regulator.

〔従来の技術〕[Conventional technology]

で示される化合物を原料にしてブラシノライド類縁体の
中間体である式 で示されるステロイド化合物を製造する方法としては、
特開昭61-69790の方法が知られている。
formula A compound which is an intermediate of a brassinolide analog using the compound represented by As a method for producing the steroid compound represented by,
The method of JP-A-61-69790 is known.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

前記特開昭61-69790に記載された方法のように、酸化剤
として硫酸中、無水クロム酸(ジョーンズ試薬)が多用
されてきたが、有毒な六価クロムを使い、反応が強酸中
で行うため保護基のついたものは使えないといった欠点
があり、工業的に実施する場合は有利とはいえない。
As in the method described in JP-A-61-69790, chromic anhydride (Jones reagent) has been frequently used as an oxidizing agent in sulfuric acid, but the reaction is carried out in a strong acid using toxic hexavalent chromium. Therefore, there is a disadvantage that a protective group cannot be used, and it cannot be said to be advantageous when it is carried out industrially.

従って、本発明者は、強酸やクロムを使わない酸化方法
を見い出すべく鋭意検討を行った。
Therefore, the present inventor has conducted earnest studies to find an oxidation method that does not use strong acid or chromium.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者は、式 (式中、R1 を示し、R2はメチル基またはエチル基を示し、*は基R1
のステロイド核への結合部位を示す)で示される化合物
を出発原料に用い、酸化条件を種々検討した結果目的と
する式 で示される化合物をジョーンズ試薬を使うことなく製造
できる方法を見い出した。
The inventor (Where R 1 , R 2 represents a methyl group or an ethyl group, and * represents a group R 1
The binding site to the steroid nucleus of) is used as a starting material, and various oxidation conditions have been investigated. We have found a method by which the compound shown by can be prepared without using Jones reagent.

以下本発明を詳細に説明する。The present invention will be described in detail below.

式(1)の化合物を四級アンモニウムハライド塩の存在
下、適当な溶媒中、N−ハロカルボン酸アミドを用いて
酸化させて目的とする式(2)で示される化合物を得る
ことができる。
The compound of formula (1) can be oxidized with an N-halocarboxylic acid amide in the presence of a quaternary ammonium halide salt in a suitable solvent to obtain the desired compound of formula (2).

この反応において、四級アンモニウムハライドとしては
例えば塩化テトラ−n−ブチルアンモニウム、臭化テト
ラ−n−ブチルアンモニウム、ヨウ化テトラ−n−ブチ
ルアンモニウム、塩化ベンジルトリエチルアンモニウ
ム、臭化ベンジルトリエチルアンモニウム、ヨウ化ベン
ジルトリエチルアンモニウム、塩化ベンジルトリメチル
アンモニウム、臭化ベンジルトリメチルアンモニウム、
ヨウ化ベンジルトリメチルアンモニウムなどがあげら
れ、この中では特にヨウ化テトラ−n−ブチルアンモニ
ウムが好ましい。これらの塩の量は式(1)の化合物1
モルに対し、1.0〜5.0モル用いるのが好ましい。
In this reaction, examples of the quaternary ammonium halide include tetra-n-butylammonium chloride, tetra-n-butylammonium bromide, tetra-n-butylammonium iodide, benzyltriethylammonium chloride, benzyltriethylammonium bromide and iodide. Benzyltriethylammonium, benzyltrimethylammonium chloride, benzyltrimethylammonium bromide,
Examples thereof include benzyltrimethylammonium iodide, and among them, tetra-n-butylammonium iodide is particularly preferable. The amount of these salts is the amount of compound 1 of formula (1)
It is preferable to use 1.0 to 5.0 mol per mol.

酸化剤として用いることのできるN−ハロカルボン酸ア
ミドとしては、N−ブロモコハク酸イミド、N−ヨード
コハク酸イミド、N−ブロモフタルイミド、N−ヨード
フタルイミド、N−ブロモアセトアミド、N−ヨードア
セトアミド、N−ブロモカプロラクタム、N−ヨードカ
プロラクタムなどがあげられ、これらは式(1)の化合
物1モルに対し2〜10モル用いるのが好ましい。
Examples of the N-halocarboxylic acid amide that can be used as an oxidizing agent include N-bromosuccinimide, N-iodosuccinimide, N-bromophthalimide, N-iodophthalimide, N-bromoacetamide, N-iodoacetamide, and N-bromo. Examples thereof include caprolactam and N-iodocaprolactam, and these are preferably used in an amount of 2 to 10 mol per mol of the compound of the formula (1).

次に溶媒としては、脂肪族又は芳香族炭化水素類、例え
ば、塩化メチレン、クロロホルム、四塩化炭素、1,2−
ジクロロエタン、1,1,1−トリクロロエタン、トリクロ
ロエチレン、テトラクロロエチレン、n−ヘキサン、ベ
ンゼン、トルエン、キシレン、モノクロロベンゼン、ジ
クロロベンゼンなどがあげられる。
Next, as the solvent, aliphatic or aromatic hydrocarbons, for example, methylene chloride, chloroform, carbon tetrachloride, 1,2-
Examples thereof include dichloroethane, 1,1,1-trichloroethane, trichloroethylene, tetrachloroethylene, n-hexane, benzene, toluene, xylene, monochlorobenzene and dichlorobenzene.

また反応温度は室温〜溶媒の沸点付近が好ましい。The reaction temperature is preferably from room temperature to around the boiling point of the solvent.

〔発明の効果〕〔The invention's effect〕

本発明の方法により式(1)の化合物を出発原料に用い
目的とする式(2)の化合物が、強酸や有毒な六価クロ
ム化合物を使うことなく、さらに、反応温度を下げる必
要もなく、しかも収率が90%以上で製造できるようにな
ったため、工業的にも十分実施できるようになった。
According to the method of the present invention, the compound of formula (1) is used as a starting material, and the desired compound of formula (2) does not use a strong acid or a toxic hexavalent chromium compound, and further, it is not necessary to lower the reaction temperature. Moreover, since the production can be performed at a yield of 90% or more, it can be industrially sufficiently implemented.

〔実施例〕〔Example〕

以下実施例により本発明を説明する。 The present invention will be described below with reference to examples.

実施例1. (22E、24R)−3α,5−Cyclo−5α−ergost−22−en
−6−oneの合成: N−ヨードコハク酸イミド1.13g(5mmol)とヨウ化テト
ラ−n−ブチルアンモニウム0.37g(1mmol)を塩化メチ
レン10mlにとかしておきそこにi−ブラシカステロール
0.40g(1mmol)の塩化メチレン3ml溶液を滴下し、室温
で10時間反応させるか、40℃で3時間反応させた後、チ
オ硫酸ナトリウムの飽和水溶液20mlを加え、塩化メチレ
ン層を分離し、飽和食塩水で洗ってから、硫酸ナトリウ
ムで乾燥した。溶媒を減圧下に留去後、粗生成物をシリ
カゲルカラムクロマトグラフィで精製(溶出液n−ヘキ
サン−酢酸エチル)して目的の(22E,24R)−3α,5−C
yclo−5α−ergost−22−en−6−one0.38g(収率96
%)をえた。
Example 1. (22E, 24R) -3α, 5-Cyclo-5α-ergost-22-en
Synthesis of -6-one: 1.13 g (5 mmol) of N-iodosuccinimide and 0.37 g (1 mmol) of tetra-n-butylammonium iodide were melted in 10 ml of methylene chloride and then added to i-brasscasterol.
A 0.40 g (1 mmol) solution of methylene chloride in 3 ml was added dropwise, and the mixture was reacted at room temperature for 10 hours or at 40 ° C. for 3 hours, and then 20 ml of a saturated aqueous solution of sodium thiosulfate was added to separate the methylene chloride layer, and saturated It was washed with brine and dried over sodium sulfate. After evaporating the solvent under reduced pressure, the crude product was purified by silica gel column chromatography (eluent n-hexane-ethyl acetate) to obtain the desired (22E, 24R) -3α, 5-C.
yclo-5α-ergost-22-en-6-one 0.38 g (yield 96
%).

mp 107-109℃(文献値1)m.p.108-110℃) IR:1680cm-1(νc=o) NMR:δ0.73(s,3H,18-CH3) 1.01(s,3H,19-CH3) 5.1〜5.3(m,2H,22−および23−H) 文献1)M.J.Thompson et al.,Steroids,7,745(1965) 実施例2. 24S−Ethy1−3α,5−Cyclo−5α−Cholest−22E−en
−6−oneの合成: i−スティグマステロール0.41g(1mmol)から実施例1
と同様に反応させて、シリカゲルカラムで精製し目的と
するケトンを0.38g(収率92.5%)をえた。
mp 107-109 ° C (literature value 1) mp 108-110 ° C IR: 1680cm -1 (νc = o) NMR: δ 0.73 (s, 3H, 18-CH 3 ) 1.01 (s, 3H, 19-CH 3 ) 5.1-5.3 (m, 2H, 22- and 23-H) Reference 1) MJThompson et al., Steroids, 7 , 745 (1965) Example 2. 24S-Ethy1-3α, 5-Cyclo-5α-Cholest- 22E-en
Synthesis of -6-one: From 0.41 g (1 mmol) of i-stigmasterol to Example 1
The reaction was conducted in the same manner as in (1) and the product was purified by a silica gel column to obtain 0.38 g (yield 92.5%) of the desired ketone.

mp 106-107℃(文献値2)mp 102-103℃) IR:1675cm-1(νc=o) 文献2)K.Mori et al.,Tetrahedron,38,2099(1982) 実施例3 N−ヨードフタル酸イミド1.37g(5mmol)とヨウ化テト
ラ−n−ブチルアンモニウム0.37g(1mmol)を塩化メチ
レン10mlにとかしておき、そこにi−ブラシカステロー
ル0.40g(1mmol)の塩化メチレン3ml溶液を滴下し、実
施例1と同様に反応、後処理し、シリカゲルカラムクロ
マトで精製して(22E,24R)−3α,5−Cyclo−5α−er
gost−22−en−6−one 0.38gをえた。
mp 106-107 ℃ (reference value 2) mp 102-103 ℃ IR: 1675cm -1 (νc = o) Reference 2) K.Mori et al., Tetrahedron, 38 , 2099 (1982) Example 3 N-iodophthalate 1.37 g (5 mmol) of acid imide and 0.37 g (1 mmol) of tetra-n-butylammonium iodide were dissolved in 10 ml of methylene chloride, and a solution of 0.40 g (1 mmol) of i-brasscasterol in 3 ml of methylene chloride was added dropwise thereto. The reaction, post-treatment and purification by silica gel column chromatography were carried out in the same manner as in Example 1 to obtain (22E, 24R) -3α, 5-Cyclo-5α-er.
0.38 g of gost-22-en-6-one was obtained.

フロントページの続き (56)参考文献 特開 昭56−161384(JP,A) J.Chem.Soc.Chem.Co mmun No.18(1984)P,1236− 1238 J.Chem.Soc.Perkin Trans I No.2(1983)P. 383−386 J.Chem.Soc.Perkin Trans I No.2(1983)P. 379−382 Chem.Pharm.Bull.Vo l.30,No.11(1982)P.4181−4185 Tetrahedron Vol.38, No.14(1982)P.2099−2109 Steroids Vol.38,No. 5(1981)P.567−580 Agric.Biol.Chem.Vo l.45,No.11(1981)P.2579−2585Continuation of front page (56) Reference JP-A-56-161384 (JP, A) J. Chem. Soc. Chem. Commun No. 18 (1984) P, 1236-1238 J. Chem. Soc. Perkin Trans I No. 2 (1983) P. 383-386 J. Chem. Soc. Perkin Trans I No. 2 (1983) P. 379-382 Chem. Pharm. Bull. Vol. 30, No. 11 (1982) P. 4181-4185 Tetrahedron Vol. 38, No. 14 (1982) P. 2099-2109 Steroids Vol. 38, No. 5 (1981) P. 567-580 Agric. Biol. Chem. Vol. 45, No. 11 (1981) P. 2579-2585

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】式 (式中、R1を示し、R2はメチル基又はエチル基を示し、*は基R1
ステロイド核への結合部位を示す。)で示される化合物
を、四級アンモニウムハライドの存在下ハロゲン化炭化
水素系溶媒中、N−ハロカルボン酸アミドを用いて酸化
させることを特徴とする式 (式中、R1は前記と同じものを意味する) で示されるステロイド化合物の製法。
1. A formula (In the formula, R 1 is R 2 represents a methyl group or an ethyl group, and * represents a binding site of the group R 1 to the steroid nucleus. ) Is oxidized with a N-halocarboxylic acid amide in a halogenated hydrocarbon solvent in the presence of a quaternary ammonium halide. (Wherein R 1 has the same meaning as described above).
JP22484386A 1986-09-25 1986-09-25 Method for producing steroid compound Expired - Lifetime JPH07116217B2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP22484386A JPH07116217B2 (en) 1986-09-25 1986-09-25 Method for producing steroid compound
US07/096,433 US4891168A (en) 1986-09-25 1987-09-15 Process for producing steroid derivatives
IL83916A IL83916A (en) 1986-09-25 1987-09-16 Process for producing steroid derivatives
EP87113893A EP0261656A1 (en) 1986-09-25 1987-09-23 A process for producing steroid derivatives
CN198787106588A CN87106588A (en) 1986-09-25 1987-09-25 The method for preparing steroid derivatives
KR870010614A KR880003970A (en) 1986-09-25 1987-09-25 Method for producing steroid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22484386A JPH07116217B2 (en) 1986-09-25 1986-09-25 Method for producing steroid compound

Publications (2)

Publication Number Publication Date
JPS6383096A JPS6383096A (en) 1988-04-13
JPH07116217B2 true JPH07116217B2 (en) 1995-12-13

Family

ID=16820041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22484386A Expired - Lifetime JPH07116217B2 (en) 1986-09-25 1986-09-25 Method for producing steroid compound

Country Status (1)

Country Link
JP (1) JPH07116217B2 (en)

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Agric.Biol.Chem.Vol.45,No.11(1981)P.2579−2585
Chem.Pharm.Bull.Vol.30,No.11(1982)P.4181−4185
J.Chem.Soc.Chem.CommunNo.18(1984)P,1236−1238
J.Chem.Soc.PerkinTransINo.2(1983)P.379−382
J.Chem.Soc.PerkinTransINo.2(1983)P.383−386
SteroidsVol.38,No.5(1981)P.567−580
TetrahedronVol.38,No.14(1982)P.2099−2109

Also Published As

Publication number Publication date
JPS6383096A (en) 1988-04-13

Similar Documents

Publication Publication Date Title
EP0277089A1 (en) 11-Beta-alkynyl estrenes and estradienes, their preparations and pharmaceutical compositions containing them
CH387636A (en) Process for the preparation of new phenothiazines
JP2009541315A (en) Enhanced safety and improved oxidation process useful for the production of moxidectin with stabilized 2-iodoxybenzoic acid (SIBX)
JPH07116217B2 (en) Method for producing steroid compound
JPH0641478B2 (en) New process for producing 3-oxo-4-aza-androst-1-ene 17β-ketone
IE903701A1 (en) Process for the production of chenodeoxycholic
JPH0316333B2 (en)
SE421005B (en) TRIEPOXYAND ROSE DERIVATIVES USED AS THE BASIC MATERIAL FOR PREPARING CURRENTLY EFFECTIVE STEROID SOCIETIES AND PROCEDURES FOR PREPARING THEREOF
JPH07116221B2 (en) Method for producing ursodeoxycholic acid
HU183495B (en) Process for producing 17-alpha-hydroxy- and 17a-alpha-hydroxy-d-homo-ethiocarboxylic acids
AT393683B (en) METHOD FOR PRODUCING PREDNISON DERIVATIVES
RU2103275C1 (en) 17-halogen-4-azaandrostene derivatives and method of preparation thereof
US4891168A (en) Process for producing steroid derivatives
US3136758A (en) Delta16-20-keto-pregnene derivatives and their preparation
JP2560014B2 (en) Method for producing steroid compound
JP2980992B2 (en) Method for producing 6-halogeno-2-oxapregna-4,6-dien-3-one compound
EP0071178B1 (en) Acyloxysteroids and process for producing same
EP0000546A1 (en) D-homo oxasteroids, processes for their preparation, their use in preparing pharmaceutical compositions with antiinflammatocy activity and pharmaceutical compositions containing them
KR20240048007A (en) Δ9,11 steroid synthesis
JP2631472B2 (en) Brassinosteroid derivatives and method for producing the same
JPH0160479B2 (en)
EP0528876B1 (en) 2-iodo-3-keto-delta 4 -steroids, process for producing them and their further processing
EP1281708B1 (en) Process for the preparation of 5-Formylphthalide
JP2547322B2 (en) Brassinosteroid compound and process for producing the same
JPS6362516B2 (en)